Path: Home > GB/T > Page594 > GB/T 23101.6-2022

Price & Delivery

US$289.00 · In stock · Download in 9 seconds
GB/T 23101.6-2022: Implants for surgery - Hydroxyapatite - Part 6: Powders
Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See step-by-step procedure
Status: Valid

Std ID	Version	USD	Buy	Deliver [PDF] in	Title (Description)
GB/T 23101.6-2022	English	289	Add to Cart	3 days [Need to translate]	Implants for surgery - Hydroxyapatite - Part 6: Powders

GB/T 23101.6-2022: Implants for surgery - Hydroxyapatite - Part 6: Powders

---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Implants for surgery -- Hydroxyapatite -- Part 6.Powders ICS 11.040.40 CCSC35 National Standards of People's Republic of China Surgical Implant Hydroxyapatite Part 6.Powder Part 6.Powders (ISO 13779-6.2015, MOD) Published on 2022-04-15 2023-05-01 Implementation State Administration for Market Regulation Released by the National Standardization Administration directory Preface III Introduction IV 1 Scope 1 2 Normative references 1 3 Terms and Definitions 1 4 Requirements 3 5 Production Design Requirements 5 6 Certificate of Qualification5 Appendix A (informative) Other possible characterization tests 6 Reference 8

foreword

This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1.Structure and Drafting Rules of Standardization Documents" drafted. This document is part 6 of GB (GB/T) 23101 "Hydroxyapatite for Surgical Implants". GB (GB/T)23101 has been released the following parts. --- Part 1.Hydroxyapatite ceramics; --- Part 2.Hydroxyapatite coating; --- Part 3.Chemical analysis and characterization of crystallinity and phase purity; --- Part 4.Determination of coating bond strength; --- Part 6.Powder. This document uses the redrafted method modified to adopt ISO 13779-6.2015 "Hydroxyapatite for surgical implants - Part 6.Powder". The technical differences between this document and ISO 13779-6.2015 and their reasons are as follows. --- Regarding normative reference documents, this document has made adjustments with technical differences to adapt to the technical conditions of our country and the circumstances of the adjustment. The situation is reflected in Chapter 2 "Normative References", and the specific adjustments are as follows. ● Replace ISO 13779-3 with GB/T 23101.3 which is equivalent to adopting international standards; ● Replaced ISO 24235 with JC/T 2176 which was revised to adopt international standards; ● Replacing ISO 14971 with YY/T 0316 which is equivalent to adopting international standards; ● Removed the European Pharmacopoeia. --- In "trace elements" (4.3), the test method for heavy metal content was changed from the method in the European Pharmacopoeia to the method commonly used in my country, In order to adapt to the technical conditions of our country and improve the operability. Please note that some content of this document may be patented. The issuing agency of this document assumes no responsibility for identifying patents. This document is proposed by the State Drug Administration. This document is under the jurisdiction of the National Technical Committee on Standardization of Surgical Implants and Orthopedic Devices (SAC/TC110). This document is drafted by. Tianjin Medical Device Quality Supervision and Inspection Center, State Drug Administration Medical Device Technical Review Xin, Linketai Medical Technology (Wuxi) Co., Ltd., Sichuan Medical Device Biomaterials and Products Inspection Center, Beijing Fule Technology Development Co., Ltd. Ltd. The main drafters of this document. Ma Chunbao, An Junbo, Yuan Bo, Luo Yang, Min Yue, Pan Shuo, Wei Miao, Xue Hao, Deng Xiang, Li Jialin, Huang Xiyi, Gao Guoqiang.

Introduction

As a bone repair material, hydroxyapatite is widely used in surgical implants. GB (GB/T) 23101 "Hydroxyapatite for Surgical Implants" is converted from the ISO 13779 series of standards, providing hydroxyapatite Performance requirements and related test methods for ceramics, hydroxyapatite coatings, and hydroxyapatite powders. GB (GB/T) 23101 is temporarily composed of 5 parts, including. --- Part 1.Hydroxyapatite ceramics. Specifies requirements for hydroxyapatite ceramics used as surgical implants. --- Part 2.Hydroxyapatite coating. Specifies hydroxyapatite ceramic coatings for application to metallic and non-metallic surgical implants requirements. --- Part 3.Chemical analysis and characterization of crystallinity and phase purity. Specifies hydroxyapatite-based materials, including coatings and sintered products Methods for the determination of chemical analysis, crystallinity and phase composition analysis of substances. --- Part 4.Determination of coating bond strength. Specifies a method for measuring the bond strength of hydroxyapatite coatings. --- Part 6.Powder. That is, this document specifies the requirements for the raw material of hydroxyapatite powder. Part 5 is temporarily vacant due to ISO 13779-5 vacancies. Surgical Implant Hydroxyapatite Part 6.Powder

1 Scope

This document specifies the requirements for the raw material of hydroxyapatite powder. This document applies to the production of hydroxyapatite powder raw materials for the production of surgical implants or for the production of surgical implant coatings. This document does not apply to hydroxyapatite coatings, hydroxyapatite ceramics, glass ceramics, alpha- and beta-tricalcium phosphate or other forms of phosphorus calcium acid.

2 Normative references

The contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, dated citations documents, only the version corresponding to that date applies to this document; for undated references, the latest edition (including all amendments) applies to this document. GB/T 23101.3 Surgical Implant Hydroxyapatite Part 3.Chemical Analysis and Characterization of Crystallinity and Phase Purity (GB/T 23101.3-2010, ISO 13779-3.2008, IDT) JC/T 2176 Test method for particle size distribution of fine ceramic powder Laser diffraction method (JC/T 2176-2013, ISO 24235.2007, MOD) YY/T 0316 Application of Medical Device Risk Management to Medical Devices (YY/T 0316-2016, ISO 14971.2007 Correction version, IDT) ISO 2591-1 Screening tests - Part 1.Test methods for screening of woven wire mesh and perforated metal plates (Testsie-

3 Terms and Definitions

The following terms and definitions apply to this document. 3.1 atomisation The process of producing agglomerates of nearly spherical powder particles (atomized powder) by rapidly drying suspended particles. 3.2 α-Tricalcium phosphate αtricalciumphosphate; α-TCP Compounds with crystal structures characterized by ICDDPDF09-0348. Note 1.The chemical formula is Ca3(PO4)2. Note 2.International Diffraction Data Center Powder Diffraction Card (ICDDPDF). 3.3 β-tricalcium phosphate; β-TCP Compounds with crystal structures characterized by ICDDPDF09-0169. Note 1.The chemical formula is Ca3(PO4)2. Note 2.International Diffraction Data Center Powder Diffraction Card (ICDDPDF). ...